Home >
Medicine Info >
Admenta 7 mg Tablet Xr
Loading interface...

Admenta 7 mg Tablet Xr

Manufactured bySun Pharma Laboratories Ltd.
ContainsMemantine
Description
Admenta 7 mg Tablet Xr is used in the treatment of moderate to severe dementia of Alzheimer's disease, a condition in which the patient's memory and ability to think, communicate, learn, and handle daily activities are impaired slowly. Admenta 7 mg Tablet Xr does not cure Alzheimer's disease; it improves the symptoms of the disease and delays disease progression. This medicine is not recommended for use in patients below 18 years of age.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Admenta 7 mg Tablet Xr

  • Shortness of breath
  • Hallucinations
  • Dizziness and Drowsiness
  • Irregular heart beat
  • Rapid weight gain/loss
  • Tingling of hands or feet
  • Nausea and vomiting
  • Headache
  • Body pain

Uses of Admenta 7 mg Tablet Xr

What is it prescribed for?

  • Alzheimer's disease
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required by this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to memantine or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
General warnings

Genitourinary conditions

This medicine should be used with caution in patients with genitourinary conditions due to the increased risk of severe adverse effects. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Use in children

This medicine is not recommended for use in below 18 years of age due to safety and efficacy have not been established

Seizures disorders

This medicine should be used with caution in patients who are suffering from seizures due to the increased risk of worsening of the condition. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Cardiovascular disorders

This medicine should be used with caution in patients with a known history of cardiovascular disorders due to the increased risk of serious adverse effects. Report any unusual symptoms to the doctor immediately. Close monitoring of heart function and vital signs, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Driving or operating machinery

This medicine may cause dizziness or drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Trihexyphenidyl

Trimethoprim

Azatadine

Hydroxyzine

Clidinium

Brexpiprazole

Disease interactions

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of severe adverse effects. Close monitoring of the liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney disease

This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Cardiovascular disease

This medicine should be used with caution in patients with a known history of cardiovascular disorders due to the increased risk of serious adverse effects. Report any unusual symptoms to the doctor immediately. Close monitoring of heart function and vital signs, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Seizures

This medicine should be used with caution in patients who are suffering from seizures due to the increased risk of worsening of the condition. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine with or without food. Follow all the labeled instructions while taking this medicine. A caregiver has to monitor the drug intake by the patient. Consult the doctor if you experience any undesirable side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine decreases the abnormal activity in the brain by blocking the actions of a natural substance, glutamate. This helps in improving the symptoms of Alzheimer's disease.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

NMDA receptor antagonist, Miscellaneous central nervous system agents

Schedule

Schedule H

Memantine - DrugBank [Internet]. Drugbank.ca. 2020 [cited 5 June 2020]. Available from:

https://www.drugbank.ca/drugs/DB01043

Memantine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 5 June 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a604006.html

Memantine [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 5 June 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Memantine
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 12 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.